Journal
EMBO MOLECULAR MEDICINE
Volume 9, Issue 6, Pages 816-834Publisher
WILEY
DOI: 10.15252/emmm.201607006
Keywords
HCV; hepatitis C; interferon; miRNAs; transcriptome
Categories
Funding
- Swiss National Science Foundation (SNF) [310030B_147089, 310030_166202]
- SNF Ambizione grant [PZ00P3_142636]
- SNF MD-PhD stipend [323530_145255]
- SCIEX grant [13.296]
- Swiss National Science Foundation (SNF) [310030B_147089, 323530_145255, PZ00P3_142636] Funding Source: Swiss National Science Foundation (SNF)
Ask authors/readers for more resources
Hepatitis C virus (HCV) is widely used to investigate host-virus interactions. Cellular responses to HCV infection have been extensively studied in vitro. However, in human liver, interferon (IFN)-stimulated gene expression can mask direct transcriptional responses to infection. To better characterize the direct effects of HCV infection in vivo, we analyze the transcriptomes of HCV-infected patients lacking an activated endogenous IFN system. We show that expression changes observed in these patients predominantly reflect immune cell infiltrates rather than cell-intrinsic pathways. We also investigate the transcriptomes of patients with endogenous IFN activation, which paradoxically cannot eradicate viral infection. We find that most IFN-stimulated genes are induced by both recombinant IFN therapy and the endogenous IFN system, but with lower induction levels in the latter, indicating that the innate immune response in chronic hepatitis C is too weak to clear the virus. We show that coding and non-coding transcripts have different expression dynamics following IFN treatment. Several microRNA primary transcripts, including that of miR-122, are significantly down-regulated in response to IFN treatment, suggesting a new mechanism for IFN-induced expression fine-tuning.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available